Industry Reports

CPhI Worldwide – the world’s largest pharma event, taking place in Frankfurt, Germany (5-7 November, 2019) – releases the third part of its annual report focussed on bio in China and advanced biologicals. The report highlights growing opportunities for CDMOs...

AptarGroup, Inc , a global leader in consumer dispensing, active packaging and drug delivery solutions, announced that it has acquired Noble International, a leader in drug delivery training devices and patient onboarding. This acquisition furthers Aptar’s strategy to broaden...

Thermo Fisher Scientific Inc, the world leader in serving science, has completed its previously announced acquisition of an active pharmaceutical ingredient (API) manufacturing facility from GlaxoSmithKline (GSK) for €90 million. Completion of the transaction follows the receipt of all...

Bormioli Pharma, a pharmaceutical and biopharmaceutical plastic containers, closures, and packaging accessories company headquartered in Italy, announced it completed its acquisition of Remy & Geiser (R&G), a German plastic and glass product company. According to an Oct. 8, 2019 press...

Lundbeck has agreed to acquire clinical-stage biopharmaceutical company Alder BioPharmaceuticals in a deal valued at around $1.95bn (£1.56bn). Alder BioPharmaceuticals is involved in the discovery, development and commercialisation of novel therapeutic antibodies. As per terms of the deal, Lundbeck will begin...

CPhI & P-MEC China has become Asia’s largest and most specialised pharmaceutical event. Throughout the years, the event has witnessed the country’s pharmaceutical industry progress from playing catchup with the rest of the world to leading the way. 2019’s...

Sonnet BioTherapeutics, Inc., an oncology-focused biotechnology company developing innovative targeted biologic drugs,  announced it has entered into an agreement with Relief Therapeutics Holding SA to develop atexakin alfa through the acquisition of its subsidiary, Relief Therapeutics SA, via a...